{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:11:52Z","timestamp":1784941912042,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,12]]},"DOI":"10.7759\/cureus.18710","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T06:16:20Z","timestamp":1634105780000},"source":"Crossref","is-referenced-by-count":5,"title":["The Value of Annual Glaucoma Screening for High-Risk Adults Ages 60 to 80"],"prefix":"10.7759","author":[{"given":"Karen","family":"Allison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren","family":"Besharim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.21899","article-title":"Glaucoma in adults-screening, diagnosis, and management: a review","volume":"325","author":"Stein JD","year":"2021","unstructured":"Stein JD, Khawaja AP, Weizer JS. Glaucoma in adults-screening, diagnosis, and management: a review. JAMA. 2021, 325:164-74. 10.1001\/jama.2020.21899","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.532","article-title":"Prevalence of open-angle glaucoma among adults in the United States","volume":"122","author":"Friedman DS","year":"2004","unstructured":"Friedman DS, Wolfs RC, O'Colmain BJ, et al.. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004, 122:532-8. 10.1001\/archopht.122.4.532","journal-title":"Arch Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2017.06.21","article-title":"Critical pathway for primary open angle glaucoma diagnosis","volume":"10","author":"Allocco AR","year":"2017","unstructured":"Allocco AR, Ponce JA, Riera MJ, Magurno MG. Critical pathway for primary open angle glaucoma diagnosis. Int J Ophthalmol. 2017, 10:968-72. 10.18240\/ijo.2017.06.21","journal-title":"Int J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the global burden of disease study","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators","year":"2021","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021, 9:e144-60. 10.1016\/S2214-109X(20)30489-7","journal-title":"Lancet Glob Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham YC","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014, 121:P2081-2090. 10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators","year":"2021","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021, 9:e130-43. 10.1016\/S2214-109X(20)30425-3","journal-title":"Lancet Glob Health"},{"key":"ref7","article-title":"Glaucoma","volume":"93","author":"Gupta D","year":"2016","unstructured":"Gupta D, Chen P. Glaucoma. Am Fam Physician. 2016, 93:668-674.","journal-title":"Am Fam Physician"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/2331205X.2017.1367059","article-title":"Screening for glaucoma in populations at high risk: the eye screening New York project","volume":"4","author":"Al-Aswad LA","year":"2017","unstructured":"Al-Aswad LA, Joiner DB, Wang X, et al.. Screening for glaucoma in populations at high risk: the eye screening New York project. Cogent Medicine. 2017, 4:1367059. 10.1080\/2331205X.2017.1367059","journal-title":"Cogent Medicine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archopthalmol.2011.1224","article-title":"Projected clinical outcomes of glaucoma screening in African American individuals","volume":"130","author":"Ladapo JA","year":"2012","unstructured":"Ladapo JA, Kymes SM, Ladapo JA, Nwosu VC, Pasquale LR. Projected clinical outcomes of glaucoma screening in African American individuals. Arch Ophthalmol. 2012, 130:365-72. 10.1001\/archopthalmol.2011.1224","journal-title":"Arch Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.11.1625","article-title":"The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study","volume":"124","author":"Friedman DS","year":"2006","unstructured":"Friedman DS, Jampel HD, Mu\u0148oz B. The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study. Arch Ophthalmol. 2006, 124:1625-30. 10.1001\/archopht.124.11.1625","journal-title":"Arch Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.12.1819","article-title":"The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER","volume":"119","author":"Quigley HA","year":"2001","unstructured":"Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001, 119:1819-26. 10.1001\/archopht.119.12.1819","journal-title":"Arch Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2012.02.014","article-title":"Four-year incidence of open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study","volume":"154","author":"Varma R","year":"2012","unstructured":"Varma R, Wang D, Wu C, et al.. Four-year incidence of open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study. Am J Ophthalmol. 2012, 154:315-325. 10.1016\/j.ajo.2012.02.014","journal-title":"Am J Ophthalmol"},{"key":"ref13","article-title":"The Future of Vision: Forecasting the Prevalence and Costs of Vision Problems, Final Report to Prevent Blindness, 2014; NORC at the University of Chicago. Chicago, Ill","author":"Wittenborn J","year":"2014","unstructured":"Wittenborn J, Rein D. The Future of Vision: Forecasting the Prevalence and Costs of Vision Problems, Final Report to Prevent Blindness, 2014; NORC at the University of Chicago. Chicago, Ill. NORC, University of Chicago, Chicago; 2014."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.12.1754","article-title":"The economic burden of major adult visual disorders in the United States","volume":"124","author":"Rein DB","year":"2006","unstructured":"Rein DB, Zhang P, Wirth KE, et al.. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006, 124:1754-60. 10.1001\/archopht.124.12.1754","journal-title":"Arch Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.05.024","article-title":"How eye care providers\u2019 prescribing patterns influence costs","volume":"125","author":"Newman-Casey PA","year":"2018","unstructured":"Newman-Casey PA, Woodward MA, Niziol LM, Lee PP, De Lott LB. How eye care providers\u2019 prescribing patterns influence costs. Ophthalmology. 2018, 125:332-339. 10.1016\/j.ophtha.2017.05.024","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.5479","article-title":"Self-reported function, health resource use, and total health care costs among medicare beneficiaries with glaucoma","volume":"134","author":"Prager AJ","year":"2016","unstructured":"Prager AJ, Liebmann JM, Cioffi GA, Blumberg DM. Self-reported function, health resource use, and total health care costs among medicare beneficiaries with glaucoma. JAMA Ophthalmol. 2016, 134:357-65. 10.1001\/jamaophthalmol.2015.5479","journal-title":"JAMA Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13918","article-title":"Factors Influencing vision-related quality of life according to glaucoma severity","volume":"97","author":"Chun HS","year":"2019","unstructured":"Chun HS, Sun KR, Park CK, et al.. Factors Influencing vision-related quality of life according to glaucoma severity. Acta Ophthalmol. 2019, 97:216-224. 10.1111\/aos.13918","journal-title":"Acta Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-017-0616-1","article-title":"The impact of visual symptoms on the quality of life of patients with early to moderate glaucoma","volume":"38","author":"Kim YS","year":"2018","unstructured":"Kim YS, Yi MY, Hong YJ, Park KH. The impact of visual symptoms on the quality of life of patients with early to moderate glaucoma. Int Ophthalmol. 2018, 38:1531-9. 10.1007\/s10792-017-0616-1","journal-title":"Int Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.03.009","article-title":"Glaucoma patient-reported concerns and associated factors","volume":"178","author":"Mogil RS","year":"2017","unstructured":"Mogil RS, Tirsi A, Lee JM, Tello C, Park SC. Glaucoma patient-reported concerns and associated factors. Am J Ophthalmol. 2017, 178:9-17. 10.1016\/j.ajo.2017.03.009","journal-title":"Am J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.04.024","article-title":"Locations, circumstances, and outcomes of falls in patients with glaucoma","volume":"192","author":"Sotimehin AE.","year":"2018","unstructured":"Sotimehin AE.. Locations, circumstances, and outcomes of falls in patients with glaucoma. Am J Ophthalmol. 2018, 192:131-141. 10.1016\/j.ajo.2018.04.024","journal-title":"Am J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.06.038","article-title":"The prevalence of chronic conditions and poor health among people with and without vision impairment, aged \u226565 years, 2010-2014","volume":"182","author":"Crews JE","year":"2017","unstructured":"Crews JE, Chou CF, Sekar S, Saaddine JB. The prevalence of chronic conditions and poor health among people with and without vision impairment, aged \u226565 years, 2010-2014. Am J Ophthalmol. 2017, 182:18-30. 10.1016\/j.ajo.2017.06.038","journal-title":"Am J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0119-7","article-title":"Living with glaucoma: a qualitative study of functional implications and patients' coping behaviours","volume":"15","author":"Glen FC","year":"2015","unstructured":"Glen FC, Crabb DP. Living with glaucoma: a qualitative study of functional implications and patients' coping behaviours. BMC Ophthalmol. 2015, 15:128. 10.1186\/s12886-015-0119-7","journal-title":"BMC Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-6-201309170-00686","article-title":"Screening for glaucoma: U.S. preventive services task force recommendation statement","volume":"159","author":"Moyer VA","year":"2013","unstructured":"Moyer VA. Screening for glaucoma: U.S. preventive services task force recommendation statement. Ann Intern Med. 2013, 159:484-9. 10.7326\/0003-4819-159-6-201309170-00686","journal-title":"Ann Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.01.008","article-title":"Improving follow-up and barriers for eye screenings in communities: the SToP glaucoma study","volume":"188","author":"Zhao D","year":"2018","unstructured":"Zhao D, Guallar E, Bowie JV, et al.. Improving follow-up and barriers for eye screenings in communities: the SToP glaucoma study. Am J Ophthalmology. 2018, 188:19-28. 10.1016\/j.ajo.2018.01.008","journal-title":"Am J Ophthalmology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30201-3","article-title":"Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model","volume":"7","author":"Tang J","year":"2019","unstructured":"Tang J, Liang Y, O\u2019Neill C, Kee F, Jian J, Congdon N.  . Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model. Lancet Glob Health . 2019 , 7:968-78. 10.1016\/S2214-109X(19)30201-3","journal-title":"Lancet Glob Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.05.017","article-title":"Optimizing glaucoma screening in high-risk population: design and 1-Year findings of the screening to prevent (SToP) glaucoma study","volume":"180","author":"Zhao D","year":"2017","unstructured":"Zhao D, Guallar E, Gajwani P, et al.. Optimizing glaucoma screening in high-risk population: design and 1-Year findings of the screening to prevent (SToP) glaucoma study. Am J Ophthalmology. 2017, 180:18-28. 10.1016\/j.ajo.2017.05.017","journal-title":"Am J Ophthalmology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016.j.ajo.2014.08.004","article-title":"Reframing the US preventive services task force recommendations on screening for glaucoma","volume":"158","author":"Parrish RK II","year":"2014","unstructured":"Parrish RK II. Reframing the US preventive services task force recommendations on screening for glaucoma. Am J Ophthalmology. 2014, 158:860-861. 10.1016.j.ajo.2014.08.004","journal-title":"Am J Ophthalmology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-4-201302190-00008","article-title":"Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force","volume":"158","author":"Boland MV","year":"2013","unstructured":"Boland MV, Ervin AM, Friedman DS, et al.. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013, 158:271-9. 10.7326\/0003-4819-158-4-201302190-00008","journal-title":"Ann Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.1671","article-title":"Cost-related medication nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of medicare Part D","volume":"133","author":"Blumberg DM","year":"2015","unstructured":"Blumberg DM, Prager AJ, Liebmann JM, Cioffi GA, De Moraes CG. Cost-related medication nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of medicare Part D. JAMA Ophthalmol. 2015, 133:985-96. 10.1001\/jamaophthalmol.2015.1671","journal-title":"JAMA Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67614-the-value-of-annual-glaucoma-screening-for-high-risk-adults-ages-60-to-80","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:50Z","timestamp":1707507290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67614-the-value-of-annual-glaucoma-screening-for-high-risk-adults-ages-60-to-80"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.18710","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}